Edgewise Therapeutics, Inc.
2021 Q2 - 2025 Q4 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 2,207 | 0.0% | 88,937 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 1,353 | 0.0% | 83,437 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 1,230 | 0.0% | 93,808 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 1,572 | 0.0% | 71,450 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 1,905 | 0.0% | 71,366 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 1,790 | 0.0% | 67,082 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 538 | 0.0% | 29,846 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 1,253 | 0.0% | 68,698 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 773 | 0.0% | 70,693 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 251 | 0.0% | 43,871 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 103 | 0.0% | 13,349 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 89 | 0.0% | 13,384 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 216 | 0.0% | 24,115 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 158 | 0.0% | 16,025 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 128 | 0.0% | 16,025 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 273 | 0.0% | 28,174 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 282 | 0.0% | 18,460 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 178 | 0.0% | 10,725 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 226 | 0.0% | 10,600 | 6/30/2021 |